Education
About Us
Working with TipRanks
Follow Us
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA)
:SUNPHARMA
Total Valuation
Sun Pharmaceutical Industries Limited has a market cap or net worth of ₹4.06T. The enterprise value is ₹3.93T.
Market Cap₹4.06T
Enterprise Value₹3.93T
Share Statistics
Sun Pharmaceutical Industries Limited has 2,399,276,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,399,276,400
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Sun Pharmaceutical Industries Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 29.25%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.12
Return on Invested Capital (ROIC)29.25%
Return on Capital Employed (ROCE)0.38
Revenue Per Employee12.23M
Profits Per Employee2.54M
Employee Count43,000
Asset Turnover0.57
Inventory Turnover1.13
Valuation Ratios
The current PE Ratio of Sun Pharmaceutical Industries Limited is 39.2. Sun Pharmaceutical Industries Limited’s PEG ratio is 2.61.
PE Ratio39.2
PS Ratio7.74
PB Ratio5.64
Price to Fair Value5.64
Price to FCF34.08
Price to Operating Cash Flow0.00
PEG Ratio2.61
Income Statement
In the last 12 months, Sun Pharmaceutical Industries Limited had revenue of 525.78B and earned 109.29B in profits. Earnings per share was 45.60.
Revenue525.78B
Gross Profit410.20B
Operating Income278.15B
Pretax Income137.37B
Net Income109.29B
EBITDA149.68B
Earnings Per Share (EPS)45.60
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Sun Pharmaceutical Industries Limited pays an annual dividend of ₹5.5, resulting in a dividend yield of 0.9%
Dividend Per Share₹5.5
Dividend Yield0.9%
Payout Ratio32.52%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.69
52-Week Price Change-0.46%
50-Day Moving Average1.67K
200-Day Moving Average1.68K
Relative Strength Index (RSI)71.94
Average Volume (3m)102.58K
Important Dates
Sun Pharmaceutical Industries Limited upcoming earnings date is Feb 4, 2026, TBA (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateFeb 4, 2026
Ex-Dividend DateJul 07, 2025
Financial Position
Sun Pharmaceutical Industries Limited as a current ratio of 2.89, with Debt / Equity ratio of 0.00%
Current Ratio2.89
Quick Ratio2.33
Debt to Market Cap<0.01
Net Debt to EBITDA-0.60
Interest Coverage Ratio169.28
Taxes
In the past 12 months, Sun Pharmaceutical Industries Limited has paid 27.72B in taxes.
Income Tax27.72B
Effective Tax Rate0.20
Enterprise Valuation
Sun Pharmaceutical Industries Limited EV to EBITDA ratio is 26.60, with an EV/FCF ratio of 33.33.
EV to Sales7.57
EV to EBITDA26.60
EV to Free Cash Flow33.33
EV to Operating Cash Flow28.29
Balance Sheet
Sun Pharmaceutical Industries Limited has ₹261.23B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹261.23B billion.
Cash & Marketable Securities₹261.23B
Total Debt₹0.00
Net Cash₹261.23B
Net Cash Per Share₹108.88
Tangible Book Value Per Share₹227.50
Margins
Gross margin is 78.25%, with operating margin of 52.90%, and net profit margin of 20.79%.
Gross Margin78.25%
Operating Margin52.90%
Pretax Margin26.13%
Net Profit Margin20.79%
EBITDA Margin28.47%
EBIT Margin23.97%
Analyst Forecast
The average price target for Sun Pharmaceutical Industries Limited is ₹2,005.60, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target₹2,005.60
Price Target Upside12.69% Upside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast9.26%
EPS Growth Forecast-5.47%